MRK.DE
$110.90
Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.
Intraday
Recent News
Assessing Merck KGaA (XTRA:MRK) Valuation After Recent Share Price Weakness
Merck KGaA stock overview after recent performance Merck KGaA (XTRA:MRK) has drawn fresh attention after a period of weaker share performance, including a 2.2% one-day decline and double-digit negative returns over the past month and past 3 months. See our latest analysis for Merck KGaA. At a share price of €110.75, Merck KGaA has seen momentum fade recently, with weaker 7 day and 30 day share price returns feeding into a year to date share price return of an 8.7% decline and a 1 year total...
Germany’s Merck KGaA Expects Currency Headwinds to Weigh on Earnings
The company anticipates currency headwinds would continue to weigh on its earnings this year, as the life-sciences and chemical company prepares for a leadership change.
Health Care Roundup: Market Talk
Find insight on Merck KGaA and Granules India in the latest Market Talks covering the health care sector.
Merck KGaA (MKGAF) Q4 2025 Earnings Call Highlights: Resilient Growth Amidst Challenges
Despite FX headwinds and sector-specific hurdles, Merck KGaA (MKGAF) showcases robust organic growth and strategic advancements in key segments.
Are Investors Undervaluing Merck KGaA (MKKGY) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.